Company news
Regen BioPharma, Inc. news in 2025
Regen BioPharma, Inc.'s news releases, calls and decks from 2025, newest first.
Presenting on Emerging Growth Conference 88 Day 1 on December 10; Register to live stream
December 9, 2025
Goldman Small Cap Research Publishes New Research Report on Regen BioPharma, Inc.
November 5, 2025
Presenting on Emerging Growth Conference 87 Day 2 on October 23; Register to live stream
October 22, 2025
Regen BioPharma Update on Orphan Drug Application for HemaXellerate Will Be Presented At Emerging Growth Conference on September 24, 2025
September 23, 2025
Presenting on Emerging Growth Conference 86 Day 1 on September 24; Register to live stream
September 23, 2025
Regen BioPharma Prepares Response For FDA Regarding Its Orphan Drug Application for HemaXellerate
September 16, 2025
Regen BioPharma Explores Expanded Use of HemaXellerate for Chemotherapy-Induced Bone Marrow Suppression
September 4, 2025
Presenting on Emerging Growth Conference 85 Day 1 on August 20; Register to live stream
August 19, 2025
Regen BioPharma Discusses Potential Impact of HemaXellerate on Chemotherapy Treament Market
August 15, 2025
Regen BioPharma, Inc. to Seek Orphan Drug Designation for Lead Product
July 23, 2025
Presenting on Emerging Growth Conference 83 Day 2 on June 18; Register to live stream
June 17, 2025
Presenting on Emerging Growth Conference 82 Day 2 on May 22; Register to live stream
May 21, 2025
Presenting on Emerging Growth Conference 81 Day 2 on April 17; Register to live stream
April 15, 2025
Presenting on the Emerging Growth Conference 80 Day 2 on March 27 Register Now
March 25, 2025
Presenting on the Emerging Growth Conference 79 Day 1 on February 18 Register Now
February 17, 2025